A Longitudinal Study Exploring the Role of Mental Health Symptoms and Social Support Regarding Life Satisfaction 18 Months after Initiation of Gender-Affirming Hormone Treatment.

gender diverse gender-affirming hormone therapy life satisfaction longitudinal mental health social support transgender

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
29 Jan 2023
Historique:
received: 22 12 2022
revised: 20 01 2023
accepted: 26 01 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 12 2 2023
Statut: epublish

Résumé

While positive changes in mental health have been found following gender-affirming hormone treatment (GAHT), it is unclear how pre-GAHT mental health and social support can influence treatment outcomes. To address this, a retrospective longitudinal design was used in which 137 participants completed measures of social support, anxiety, and depression prior to GAHT (T0) and a measure of life satisfaction 18 months after GAHT (T1). The data showed no significant differences in life satisfaction at T1 based on T0 caseness of anxiety or depression. It was also found that T1 life satisfaction was not predicted by levels of anxiety, depression, or social support at T0. The lack of significant differences in life satisfaction at 18 months post-GAHT based on pre-GAHT mental health, coupled with no evidence for the predictive role social support suggest that these factors are not central to long-term life satisfaction. For many, lower mental wellbeing may be part of the experience of awaiting GAHT and should not be regarded as indicative of longer-term issues. Instead, facilitation of social support connections and mental health support should be offered both concurrently with, and for those awaiting, GAHT.

Identifiants

pubmed: 36766954
pii: healthcare11030379
doi: 10.3390/healthcare11030379
pmc: PMC9914577
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : National Institute for Health Research
ID : PB-PG-0817-20003

Références

Psychol Med. 2015 Aug;45(11):2427-36
pubmed: 25804325
J Psychosom Res. 2002 Feb;52(2):69-77
pubmed: 11832252
BMC Public Health. 2020 Jan 30;20(1):138
pubmed: 32000747
J LGBT Health Res. 2007;3(4):1-14
pubmed: 19042907
J Sex Med. 2014 Dec;11(12):2976-85
pubmed: 25155247
Int J Environ Res Public Health. 2022 Jul 22;19(15):
pubmed: 35897291
PLoS One. 2020 Oct 5;15(10):e0240295
pubmed: 33017435
Am J Public Health. 2013 May;103(5):943-51
pubmed: 23488522
Int J Transgend. 2018 Apr 26;20(1):63-80
pubmed: 32999594
Int Rev Psychiatry. 2016;28(1):44-57
pubmed: 26835611
Qual Life Res. 2010 Sep;19(7):1019-24
pubmed: 20461468
Healthcare (Basel). 2022 Nov 14;10(11):
pubmed: 36421606
J Adolesc Health. 2013 Dec;53(6):791-3
pubmed: 24012067
Acad Med. 1990 Sep;65(9):586-8
pubmed: 2400477
Int J Transgend. 2019 Jun 27;20(2-3):251-262
pubmed: 32999611
Am J Orthopsychiatry. 2016 Jan;86(1):91-102
pubmed: 26752447
Int J Transgend Health. 2022 Sep 6;23(Suppl 1):S1-S259
pubmed: 36238954
J Pers Assess. 1985 Feb;49(1):71-5
pubmed: 16367493
Qual Life Res. 2006 Nov;15(9):1447-57
pubmed: 16758113
J Sex Med. 2014 Dec;11(12):2995-3001
pubmed: 25213018
J Med Ethics. 2019 Jul;45(7):480-482
pubmed: 30988174
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Qual Life Res. 2022 Sep;31(9):2695-2703
pubmed: 35412264
J Adolesc Health. 2021 Jun;68(6):1129-1134
pubmed: 33121901
Andrology. 2021 Nov;9(6):1808-1816
pubmed: 32777129
J Sex Med. 2012 Mar;9(3):743-50
pubmed: 22188877
J Affect Disord. 2018 Aug 1;235:308-315
pubmed: 29665513
Psychoneuroendocrinology. 2012 May;37(5):662-70
pubmed: 21937168
Rev Endocr Metab Disord. 2018 Sep;19(3):199-220
pubmed: 30121881
J Pers Assess. 1990 Winter;55(3-4):610-7
pubmed: 2280326
Int J Transgend. 2019 Feb 10;20(2-3):263-274
pubmed: 32999612
J Endocr Soc. 2021 Feb 02;5(4):bvab011
pubmed: 33644622

Auteurs

Zoë Aldridge (Z)

Institute of Mental Health, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham NG7 2TU, UK.
School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough LE11 3TU, UK.

Nat Thorne (N)

Nottingham Centre for Transgender Health, Nottingham NG1 3AL, UK.

Walter Pierre Bouman (WP)

Institute of Mental Health, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham NG7 2TU, UK.
Nottingham Centre for Transgender Health, Nottingham NG1 3AL, UK.

Gemma L Witcomb (GL)

School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough LE11 3TU, UK.

Jon Arcelus (J)

Institute of Mental Health, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham NG7 2TU, UK.
Nottingham Centre for Transgender Health, Nottingham NG1 3AL, UK.
Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet del Llobregat, 08908 Barcelona, Spain.

Classifications MeSH